Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
André F. Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Life Science Alliance (2020) Vol. 4, Iss. 2, pp. e202000955-e202000955
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19
Takato Kusakabe, Woan-Yu Lin, Jin‐Gyu Cheong, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1879-1889
Open Access | Times Cited: 43
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 598
Open Access | Times Cited: 82
System-wide transcriptome damage and tissue identity loss in COVID-19 patients
Jiwoon Park, Jonathan Foox, Tyler Hether, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100522-100522
Open Access | Times Cited: 39
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Improving the Efficacy of Regulatory T Cell Therapy
Paulien Baeten, Lauren Van Zeebroeck, Markus Kleinewietfeld, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 62, Iss. 2, pp. 363-381
Open Access | Times Cited: 41
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 7, pp. 100680-100680
Open Access | Times Cited: 35
The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
Maria Karoliny da Silva Torres, Carlos David Araújo Bichara, Maria de Nazaré do Socorro de Almeida, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 30
Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
Mohammad A. Al-Mterin, Alhasan Alsalman, Eyad Elkord
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Natural killer cells and unconventional T cells in COVID-19
Niklas K. Björkström, Andrea Ponzetta
Current Opinion in Virology (2021) Vol. 49, pp. 176-182
Open Access | Times Cited: 32
Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection?
Lisa Goudman, Ann De Smedt, Marc Noppen, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 23, pp. 5594-5594
Open Access | Times Cited: 32
Spectrum of hematological changes in COVID-19.
Smeeta Gajendra
PubMed (2022) Vol. 12, Iss. 1, pp. 43-53
Closed Access | Times Cited: 20
Navigating the Unknown: Open Questions Surrounding Natural Killer Cell Responses to SARS-CoV-2
Quirin Hammer
Springer eBooks (2025), pp. 1-21
Closed Access
Genetic and phenotypic analysis of the causal relationship between aging and COVID-19
Kejun Ying, Ranran Zhai, Timothy V. Pyrkov, et al.
Communications Medicine (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 26
Multimodal single-cell omics analysis identifies epithelium–immune cell interactions and immune vulnerability associated with sex differences in COVID-19
Yuan Hou, Yadi Zhou, Michaela U. Gack, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 25
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
André F. Rendeiro, Charles Kyriakos Vorkas, Jan Krumsiek, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 16
Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19
Maria O. Ustiuzhanina, Julia D. Vavilova, A. A. Boyko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1996-1996
Open Access | Times Cited: 10
HLA‐DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID‐19
Ticiana D.J. Farias, Silvia Brugiapaglia, Susanna Croci, et al.
HLA (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 9
Immunoregulatory natural killer cells
Kevin Roe
Clinica Chimica Acta (2024) Vol. 558, pp. 117896-117896
Closed Access | Times Cited: 3
Immune checkpoint inhibitors and SARS-CoV2 infection
Samaneh Abdolmohammadi‐Vahid, Behzad Baradaran, Ian M. Adcock, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112419-112419
Closed Access | Times Cited: 3
Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19
Martina Barnova, Anna Bobčáková, Veronika Urdova, et al.
Physiological Research (2021), pp. S227-S247
Open Access | Times Cited: 21
The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences
Amal F. Alshammary, Abdulrahman M. Alsulaiman
Virulence (2021) Vol. 12, Iss. 1, pp. 1771-1794
Open Access | Times Cited: 19
Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation
Abdallah Flaifel, Benjamin Kwok, Jane P. Ko, et al.
American Journal of Clinical Pathology (2021) Vol. 157, Iss. 6, pp. 908-926
Open Access | Times Cited: 18
T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis
Amal F. Alshammary, Jawaher Alsughayyir, Khalid Khalaf Alharbi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
Anna Bobčáková, Martina Barnova, Róbert Vyšehradský, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps
Jiwoon Park, Jonathan Foox, Tyler Hether, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top